Clinical Trials: Liver Transplantation

Alabama

Birmingham; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Arizona

Phoenix; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

California

La Jolla; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Los Angeles; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

San Diego ; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

San Francisco; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

San Francisco; Research Site:
A Study to Assess the Efficacy and Safety of CellCept (Mycophenolate Mofetil) in Combination With Cyclosporine and Corticosteroids in Preventing Acute Rejection in Pediatric Liver Transplant Patients

Colorado

Denver; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Florida

Jacksonville; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Miami; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Tampa; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Georgia

Atlanta; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Illinois

Chicago; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Louisiana

New Orleans; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Massachusetts

Boston; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Burlington; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Michigan

Detroit; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Minnesota

Minneapolis; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Rochester; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Missouri

St Louis; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

New Jersey

Newark; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

New York

Hawthorne; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

New York; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

New York; Research Site:
A Study to Assess the Efficacy and Safety of CellCept (Mycophenolate Mofetil) in Combination With Cyclosporine and Corticosteroids in Preventing Acute Rejection in Pediatric Liver Transplant Patients

New York; Biomedical Research Alliance of New York
Study of the Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

New York; Biomedical Research Alliance of New York
Clinical trial to test a study drug for the prevention of Cytomegalovirus Disease in Recipients of Orthotopic Liver Transplants.

North Carolina

Chapel Hill; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Ohio

Cleveland; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Oklahoma

Oklahoma City; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Pennsylvania

Philadelphia; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Tennessee

Nashville; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Texas

Dallas; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Houston; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

San Antonio; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Virginia

Charlottesville; University of Virginia
Adults undergoing Liver transplant wanted for tissue donation study.

Richmond; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Wisconsin

Madison; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

International

Bruxelles, Belgium; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Edmonton, AB, Canada; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Halifax, NS, Canada; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

London, ON, Canada; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

London, ON, Canada; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Montreal, QC, Canada; Research Site:
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Changsha, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Chengdu, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Nanjing, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Shanghai, China; Research Site:
A Study of CellCept (Mycophenolate Mofetil) Combined With Calcineurin Inhibitors in Liver Transplant Patients.

Helsinki, Finland; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Besancon, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Bordeaux, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Caen, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Clichy, France; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Clichy, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Clichy, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Creteil, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Grenoble, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Lille, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Lille, France; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Lyon, France; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Lyon, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Marseille, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Montpellier, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Nice, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Paris, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Rennes, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Toulouse, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Toulouse, France; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Villejuif, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

Villejuif, France; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Villejuif, France; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Berlin, Germany; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Berlin, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Essen, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Frankfurt Am Main, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Hannover, Germany; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Heidelberg, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Kiel, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Leipzig, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Regensburg, Germany; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Oslo, Norway; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Barcelona, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Hospitalet de Llobregat, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

La Coruna, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Madrid, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Madrid, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Pamplona, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Santiago de Compostela, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Sevilla, Spain; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Sevilla, Spain; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Goeteborg, Sweden; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Stockholm, Sweden; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Geneve, Switzerland; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

Zürich, Switzerland; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

Birmingham, United Kingdom; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation

London, United Kingdom; Research Site:
A Study of CellCept (Mycophenolate Mofetil) in Liver Transplant Patients

London, United Kingdom; Research Site:
(Elite ReSpECT Study) - A Study of Zenapax (Daclizumab) in Patients Who Have Undergone Liver Transplantation